The Jackson laboratory investigates the critical issue of anti-mycobacterial multi-drug resistance by studying biosynthesis of the mycobacterial cell envelope. This research elucidates pathways in the biosynthesis and transport of glycolipids, fatty acids and polysaccharides that play important roles in the physiology and pathogenicity of M. tuberculosis. Dr. Jackson also studies emerging non-tuberculous mycobacterial pathogens, the strategies used by these organisms to persist in the environment and their molecular mechanisms of pathogenicity and resistance to biocides.
People
news and updates view all
Using the only approved TB vaccine Mary Jackson and her team are producing novel COVID-19 vaccine candidates.
On International Women’s Day, we celebrate the contributions and impact from women everywhere, including all of the CSU scientists and researchers who have led in the fight against COVID-19
Adaption of a current tuberculosis vaccine may prove effective in fighting SARS-CoV-2.
contact information
Lab: Microbiology rooms B425, B426, B427
Office: Microbiology room B423A
(970) 491-4067
mary.jackson@colostate.edu